Collings A, Raitakari O T, Juonala M, Rontu R, Kähönen M, Hutri-Kähönen N, Rönnemaa T, Marniemi J, Viikari J S A, Lehtimäki T
Department of Clinical Chemistry, Centre for Laboratory Medicine, Tampere University Hospital, and Medical School at the University of Tampere, Finland.
Scand J Clin Lab Invest. 2008;68(1):22-30. doi: 10.1080/00365510701487735. Epub 2007 Nov 21.
To study whether the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism or serum homocysteine concentration is associated with carotid artery intima media thickness (IMT), carotid artery compliance (CAC) or brachial artery flow mediated dilatation (FMD) in a healthy Finnish adult population.
Cross-sectional data obtained in 2001 for the Cardiovascular Risk in Young Finns Study were used. Carotid artery IMT, CAC and brachial FMD were measured by ultrasound and serum homocysteine concentrations using a commercial immunoassay kit. We studied 1,440 subjects (aged 24-39 years). Genotyping was performed using the 5' nuclease TaqMan assay.
Homocysteine values differed between genotypes in women and men (ANOVA, p<0.001 for both sex groups): the genotype raised values in the order of CC, CT, TT. There was a significant difference in CAC values between the MTHFR genotypes in men (ANOVA, p = 0.008), and the CC genotype had the lowest values. In multivariate linear regression analysis adjusted for other major coronary risk factors (e.g. age, smoking, body mass index, systolic blood pressure, C-reactive protein), the association remained significant (R (2) = 25.8 %, beta = 0.091; p = 0.02). Homocysteine level was directly associated with CAC in the whole population (R (2) = 18.0 %, beta = 0.012; p = 0.014) and in women (R (2) = 9.3%, beta = 0.02; p = 0.013), but not in men (R (2) = 15.2 %, beta = 0.004; p = 0.444). We found no association between homocysteine level or the MTHFR polymorphism and carotid IMT or brachial artery FMD.
The findings suggest that the MTHFR polymorphism does not influence IMT or FMD, but that the T allele may have an effect on CAC in men.
研究在健康的芬兰成年人群中,亚甲基四氢叶酸还原酶(MTHFR)C677T基因多态性或血清同型半胱氨酸浓度是否与颈动脉内膜中层厚度(IMT)、颈动脉顺应性(CAC)或肱动脉血流介导的血管舒张功能(FMD)相关。
使用2001年从芬兰青年人心血管风险研究中获得的横断面数据。通过超声测量颈动脉IMT、CAC和肱动脉FMD,并使用商用免疫分析试剂盒测定血清同型半胱氨酸浓度。我们研究了1440名受试者(年龄在24 - 39岁之间)。采用5'核酸酶TaqMan分析法进行基因分型。
男性和女性不同基因型的同型半胱氨酸值存在差异(方差分析,两性组p均<0.001):基因型升高导致同型半胱氨酸值按CC、CT、TT顺序升高。男性MTHFR基因型之间的CAC值存在显著差异(方差分析,p = 0.008),CC基因型的值最低。在针对其他主要冠状动脉危险因素(如年龄、吸烟、体重指数、收缩压、C反应蛋白)进行调整的多变量线性回归分析中,这种关联仍然显著(R(2)=25.8%,β = 0.091;p = 0.02)。同型半胱氨酸水平在整个人群(R(2)=18.0%,β = 0.012;p = 0.014)和女性(R(2)=9.3%,β = 0.02;p = 0.013)中与CAC直接相关,但在男性中不相关(R(2)=15.2%,β = 0.004;p = 0.444)。我们未发现同型半胱氨酸水平或MTHFR基因多态性与颈动脉IMT或肱动脉FMD之间存在关联。
研究结果表明,MTHFR基因多态性不影响IMT或FMD,但T等位基因可能对男性的CAC有影响。